Imidazoline receptors: from discovery to antihypertensive therapy (facts and doubts)
- 23 July 1999
- journal article
- review article
- Published by Elsevier BV in Brain Research Bulletin
- Vol. 49 (5), 317-331
- https://doi.org/10.1016/s0361-9230(99)00057-x
Abstract
No abstract availableKeywords
This publication has 189 references indexed in Scilit:
- Densities of I2-imidazoline receptors, α2-adrenoceptors and monoamine oxidase B in brains of suicide victimsNeurochemistry International, 1997
- Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitroNeuroscience Letters, 1995
- Characterization of imidazoline binding protein(s) solubilized from human brainstem: Studies with [3H]idazoxan and [3H]clonidineNeurochemistry International, 1994
- Phosphatidylcholine breakdown and signal transductionBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Expression of non‐adrenergic imidazoline sites in rat cerebral cortical astrocytesJournal of Neuroscience Research, 1993
- Heterogeneity of the specific imidazoline binding of [3H]idazoxan in the human cerebral cortexNeurochemistry International, 1993
- Production and characterization of an iminoimidazolidine specific monoclonal antibody using para-aminoclonidine as antigenLife Sciences, 1992
- Evidence for imidazoline binding sites in basolateral membranes from rabbit kidneyBiochemical and Biophysical Research Communications, 1987
- An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medullaLife Sciences, 1986
- An endogenous brain substance, CDS (clonidine-displacing-substance), inhibits the twitch response of rat vas deferensBiochemical and Biophysical Research Communications, 1986